WHO Approves First Mpox Vaccine for Adults in Africa — Then Says Babies Can Get It, Too, Despite No Clinical Trials

The WHO said that while Bavarian Nordic’s MVA-BN vaccine is not licensed for people under age 18, it may be used in infants, children and adolescents “in outbreak settings where the benefits of vaccination outweigh the potential risks.”

https://childrenshealthdefense.org/defender/who-africa-mpox-vaccine-adults-no-trials-babies-pregnant-women/